Dr. Susanna Naggie completed her undergraduate degrees in chemical engineering and biochemistry at the University of Maryland, College Park, and her medical education at Johns Hopkins School of Medicine. She conducted her internal medicine and infectious diseases fellowship training at Duke Health. She joined the faculty in the Duke School of Medicine in 2009. She is a Professor of Medicine and currently holds appointments at the Duke School of Medicine, Duke Clinical Research Institute, and Durham Veterans Affairs Medical Center. Dr.

Dr. Squires earned his medical degree from the University of Texas and went on to complete his training in general pediatrics at the Cincinnati Children's Hospital Medical Center (CCHMC). Following residency, he completed fellowships in both pediatric gastroenterology and pediatric advanced/transplant hepatology at CCHMC and completed a Masters in clinical and translational at the University of Cincinnati. Following completion of his training, Dr.

Dr Giada Sebastiani is a Professor of Medicine and Clinician Scientist at the McGill University Health Centre. Her clinical and research expertise focuses on metabolic dysfunction-associated steatotic liver disease (MASLD) and non-invasive diagnostics in liver disease, with a strong emphasis on vulnerable and underserved populations. She leads a nationally-funded research program, integrating epidemiology, patient-centered strategies, and policy translation. Dr Sebastiani is the President of the Canadian Association for the Study of the Liver and co-founder of the Canadian MASLD Network.

Aly Strauss is a hepatologist and Assistant Professor of Medicine at Johns Hopkins University School of Medicine. Dr. Strauss completed her Masters in Industrial Engineering at the University of South Florida and her PhD in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Currently, she is the Co-Director of the Clinical and Translational Research Unit for the Division of Gastroenterology and Hepatology. Dr.

Dr. Gupta, MD, MPH, is the Chief Technical Officer for the Coalition for Global Hepatitis Elimination. Dr. Gupta is a specialist in internal medicine, pediatrics, and public health, and is an Assistant Professor of Medicine at Harvard Medical School and Associate Physician at the Division of Global Health Equity at Brigham & Women's Hospital in Boston, USA. Dr. Gupta has worked extensively in sub-Saharan Africa to support viral hepatitis programs and research initiatives.

Dr. Kushner is an Associate Professor in the Division of Gastroenterology & Hepatology at Weill Cornell Medicine, and holds a joint appointment in the Divisions of Obstetrics & Gynecology and Population Health Sciences. She has a clinical and research focus on liver disease in pregnancy and in viral hepatitis.

Dr. Khaderi is a transplant hepatologist at Baylor St. Luke's Medical Center in Houston, Texas. She is the Education Lead for the Hepatitis C SIG and a former member of AASLD's Women's Initiative Committee.

Physician Assistant practicing general hepatology at academic, liver transplant center as of 2001.

Dr. Schwarz received her bachelor's degree in biology from Scripps College, her MAT in biology from Northwestern University and her medical degree from Washington University in St. Louis, Missouri. She then completed her residency in Pediatrics and fellowship in Pediatric Gastroenterology at St. Louis Children's Hospital, Washington University School of Medicine. She has been triply boarded by the American Board of Pediatrics in Pediatrics, Pediatric Gastroenterology and Pediatric Transplant Hepatology. She was Chief of Pediatric Gastroenterology at St.

I received my MD at Russian University of Friendship, Moscow. I then studied biochemistry and immunology during my graduate studies at Christian-Albrecht University, Germany. As a postdoctoral fellow at Columbia University (USA), I studied signal transduction, and expanded my skills in transgenic mouse technologies. I joined UCSD as a principal investigator. The major interest of my research is the identification of new targets for the therapy of MASH and MetALD-associated liver fibrosis and cholestatic fibrosis.